©The Author(s) 2025.
World J Diabetes. Aug 15, 2025; 16(8): 106215
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.106215
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.106215
Table 3 Baseline measurements of atherosclerotic variables
| Variables | Intervention group (APRG) | Control group (SC) | P value |
| Pain score | 6.44 ± 0.34 | 6.44 ± 0.41 | 0.982 |
| ABI | 0.56 ± 0.55 | 0.55 ± 0.64 | 0.896 |
| Walking distance (m) | 109.53 ± 11.73 | 110.96 ± 15.66 | 0.531 |
| Claudication severity | 2.34 ± 1.62 | 2.33 ± 1.56 | 0.869 |
| Wound healing rate (%) | 32.23 ± 14.03 | 33.02 ± 12.85 | 0.723 |
| Flow value (mL/minute) | 24.75 ± 3.42 | 24.76 ± 4.15 | 0.880 |
- Citation: Chen M, Li JT, Gao JB, Zhang L, Gao QH, Zeng X, Liu Q. Autologous platelet rich gel in treatment of lower limb atherosclerotic occlusive disease in diabetic patients. World J Diabetes 2025; 16(8): 106215
- URL: https://www.wjgnet.com/1948-9358/full/v16/i8/106215.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i8.106215